REGISTRY SNAPSHOT: National Food and Drug Surveillance Institute (INVIMA)

by Staff writer,
Posted on 4/23/2019

Knowing which countries to submit clinical trial results summaries to is the easy part. What becomes difficult is learning the intricacies and transparency requirements of every clinical trial registry globally, including the National Food and Drug Surveillance Institute (INVIMA) in Colombia. Here is an overview of this registry:

bogota columbia

A street in Bogota, Colombia.

Registry name: National Food and Drug Surveillance Institute (INVIMA)

Country: Colombia

Year established: 2012

Points of interest:

  • Clinical trials in Colombia must be reported to INVIMA
  • In 2012, INVIMA was restructured to take on additional responsibilities for the country’s public health, including increased transparency and surveillance measures
  • Protocol registration for all interventional clinical trials occurring in Colombia are mandatory, in the Spanish language
  • The principal clinical trial researcher must submit written summaries covering the status of the study to a research ethics committee at least once a year
  • The researcher must notify the INVIMA of any significant change that affects the conduct of the trial
  • Regardless of the study’s outcomes, the principal researcher is responsible for disseminating the study data is disseminated among the scientific community
  • Under the Colombian Data Privacy Law (1581/2012), clinical trial data is considered a “special data category” because it encompasses personal health data. As such, the researchers must obtain written consent from subjects.

Related transparency research/articles:

TrialAssure® Registry can automate the disclosure of clinical trial results for the National Food and Drug Surveillance Institute (INVIMA). For questions or a free demo, fill out this form.

Share: